Parnassus Investments Portfolio holdings
AUM
$43.3B
1-Year Est. Return
17.24%
1 Year Est. Return
+17.24%
AUM
$43.4B
AUM Growth
+$1.74B
(+4.2%)
Holding
157
Top Buys
| 1 | +$492M | |
| 2 | +$302M | |
| 3 | +$105M | |
| 4 |
Alcon
ALC
|
+$80.9M |
| 5 |
Synopsys
SNPS
|
+$60.5M |
Top Sells
| 1 | +$859M | |
| 2 | +$601M | |
| 3 | +$209M | |
| 4 |
Pfizer
PFE
|
+$112M |
| 5 |
Simon Property Group
SPG
|
+$111M |
Sector Composition
| 1 | Technology | 34.06% |
| 2 | Financials | 16.65% |
| 3 | Industrials | 12.24% |
| 4 | Healthcare | 11.49% |
| 5 | Consumer Discretionary | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Pfizer
PFE
$191B
| – | – |
-4,401,705
|
|
||
152
KeyCorp
KEY
$19.3B
| – | – |
-2,271,400
|
|
||
153
Hologic
HOLX
$16.5B
| – | – |
-726,871
|
|
||
154
Global Payments
GPN
$18.9B
| – | – |
-1,098,035
|
|
||
155
Gilead Sciences
GILD
$153B
| – | – |
-642,590
|
|
||
156
Fortinet
FTNT
$65.3B
| – | – |
-404,370
|
|
||
157
Baxter International
BAX
$9.21B
| – | – |
-2,303,048
|
|